Cargando…
A child with resistant Kawasaki disease successfully treated with anakinra: a case report
BACKGROUND: Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown etiology. Intravenous immunoglobulin (IVIG) is an effective treatment and decreases the risk of cardiac complications to less than 5%. In spite of its effectiveness, some children do not respond to this therapy...
Autores principales: | Sánchez-Manubens, J., Gelman, A., Franch, N., Teodoro, S., Palacios, J. R., Rudi, N., Rivera, J., Antón, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385011/ https://www.ncbi.nlm.nih.gov/pubmed/28390409 http://dx.doi.org/10.1186/s12887-017-0852-6 |
Ejemplares similares
-
Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020) -
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review
por: Ferrara, Giovanna, et al.
Publicado: (2020) -
High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report
por: Shafferman, Ashley, et al.
Publicado: (2014) -
Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma Successfully Treated by Anakinra
por: Faheem, Beenish, et al.
Publicado: (2020) -
Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
por: Cattaneo, Paolo, et al.
Publicado: (2021)